Valproate acid is named as an intervention in 2 current clinical trials in our Germany, Spain, Italy, Austria and Israel registers. 2 are recruiting patients now. All registered phases are Phase 3. The lead sponsor is Dr. Inge Winter. The most-studied condition is Bipolar Depression.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
NCT05603104 · ClinicalTrials.gov ↗ · Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression
|
Phase 3 | Recruiting | Dr. Inge Winter | Israel |
|
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
NCT05973786 · ClinicalTrials.gov ↗ · Bipolar Depression
|
Phase 3 | Recruiting | Dr. Inge Winter | Germany, Spain, Italy, Austria |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Dr. Inge Winter | 2 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Germany | 1 | 1 |
| Clinical trials in Spain | 1 | 1 |
| Clinical trials in Italy | 1 | 1 |
| Clinical trials in Austria | 1 | 1 |
| Clinical trials in Israel | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our Germany, Spain, Italy, Austria and Israel registers name Valproate acid (also registered as ATC code: N03AG01) as a drug or biological intervention, as of the registry sync on 28 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 2 trials are recruiting: 1 with sites in Germany, 1 with sites in Spain, 1 with sites in Italy, 1 with sites in Austria and 1 with sites in Israel. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
The lead sponsor is Dr. Inge Winter. The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Valproate acid works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Valproate acid works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Valproate acid (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 28 Sep 2026.